The worldwide chronic myelomonocytic leukemia (CMML) treatment market is experiencing a period of significant growth. This expansion can be attributed to several factors, like the increasing incidence of CMML, advancements in treatment, and expanding awareness about the disease. The market is defined by a wide range of selection of treatments avail